3rd Quarter - Report

FOLEY HOAG LLP for CUBIST PHARMACEUTICALS

Firm
Client
Income
$54,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S.3187, Food and Drug Administration Safety and Innovation Act; Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011

LobbyistCovered position, as disclosed
J KEVIN BRENNAN —
PAUL KIM —
NICK LITTLEFIELD —
ROSS DAVID MARGULIES —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 3187 (112th), H.R. 1483 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.